ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience
Biz Wire Express,
GlobeNewswire 2022-10-25 Data Shows ReShape’s DBSN™ System has Promise as a Novel, Adjustable and Localized Approach to Treat…